Related Experiment Video
Updated: Oct 21, 2025

10:31
Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
374
Single Cell Transcriptome Helps Better Understanding Crosstalk in Diabetic Kidney Disease
Chunyang Du1, Yunzhuo Ren1, Guixin Li2
1Key Laboratory of Kidney Diseases of Hebei Province, Department of Pathology, Hebei Medical University, Shijiazhuang, China.
Frontiers in Medicine
|September 6, 2021
Summary
Diabetic kidney disease (DKD) involves complex cell interactions. Single-cell RNA sequencing reveals cellular details, offering new therapeutic targets for DKD treatment.
Area of Science:
- Nephrology
- Genomics
- Molecular Biology
Background:
- Diabetic kidney disease (DKD) pathogenesis involves intricate crosstalk among kidney cells, factors, and metabolites.
- Cellular heterogeneity and genetic susceptibility in DKD are crucial areas of study.
- Understanding cell-specific processes is key to deciphering DKD development.
Purpose of the Study:
- To review recent advancements in single-cell transcriptomic analyses of DKD.
- To highlight intra- and extra-glomerular cell crosstalk in DKD.
- To identify potential cellular targets and therapeutic strategies for DKD.
Main Methods:
- Review of single-cell RNA sequencing (scRNA-seq) studies focused on DKD.
- Analysis of cellular heterogeneity and cell-cell interactions in DKD models.
- Integration of transcriptomic data to understand DKD pathophysiology.
Main Results:
- scRNA-seq provides unprecedented resolution into cell-specific DKD mechanisms.
- Identification of key cell types and signaling pathways involved in DKD progression.
- Emerging insights into the role of cell crosstalk in DKD pathogenesis.
Conclusions:
- Single-cell transcriptomics is revolutionizing DKD research by elucidating cellular complexity.
- Targeting specific cell-cell interactions and pathways holds promise for novel DKD therapies.
- Further research using scRNA-seq can refine therapeutic strategies for diabetic kidney disease.

